Document Detail


Mechanisms of hypertension: the expanding role of aldosterone.
MedLine Citation:
PMID:  15284285     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypertension is a common disorder that affects a large heterogeneous patient population. Subgroups can be identified on the basis of their responses to hormonal and biologic stimuli. These subgroups include low-renin hypertensives and nonmodulators. Aldosterone, the principal human mineralocorticoid, is increasingly recognized as playing a significant role in cardiovascular morbidity, and its role in hypertension has recently been reevaluated with studies that suggest that increased aldosterone biosynthesis (as defined by an elevated aldosterone to renin ratio) is a key phenotype in up to 15% of individuals with hypertension. It was reported previously that a polymorphism of the gene (C to T conversion at position -344) encoding aldosterone synthase is associated with hypertension, particularly in individuals with a high ratio. However, the most consistent association with this variant is a relative impairment of adrenal 11beta-hydroxylation. This review explores the evidence for this and provides a hypothesis linking impaired 11beta-hydroxylation and hypertension with a raised aldosterone to renin ratio. It is also speculated that there is substantial overlap between this group of patients and previously identified low-renin hypertensives and nonmodulators. Thus, these groups may form a neurohormonal spectrum reflecting different stages of hypertension or indeed form sequential steps in the natural history of hypertension in genetically susceptible individuals.
Authors:
E Marie Freel; John M C Connell
Related Documents :
16115515 - Neurohumoral pathways in heart failure with preserved systolic function.
14621105 - Fluid homeostasis in chronic obstructive lung disease.
23214685 - Energy partition at the collapse of spherical cavitation bubbles.
15173035 - Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with...
16540495 - A small amount of inhaled nitric oxide does not increase lung diffusing capacity.
8282375 - Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of the American Society of Nephrology : JASN     Volume:  15     ISSN:  1046-6673     ISO Abbreviation:  J. Am. Soc. Nephrol.     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-08-02     Completed Date:  2004-09-20     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  9013836     Medline TA:  J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1993-2001     Citation Subset:  IM    
Affiliation:
MRC Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone / physiology*
Humans
Hypertension, Renal / genetics,  metabolism,  physiopathology*
Grant Support
ID/Acronym/Agency:
069205//Wellcome Trust
Chemical
Reg. No./Substance:
52-39-1/Aldosterone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endothelial dysfunction.
Next Document:  Differential regulation of basolateral Cl-/HCO3- exchangers SLC26A7 and AE1 in kidney outer medullar...